ARTHEx Biotech S.L.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ARTHEx Biotech S.L. - overview
Established
2019
Location
Valencia, -, Spain
Primary Industry
Biotechnology
About
Founded in 2019 in and based in Valencia, Spain, ARTHEx Biotech S. L is a biotechnology company focused on developing innovative medicines through the investigation of antimiRs, a new class of therapeutic agents targeting microRNAs. In September 2025, ARTHEx Biotech S. L raised an undisclosed amount of series B funding led by new investor Bpifrance.
Returning investors AdBio Partners, Center for Technological & Industrial Development, Columbus Venture Partners, European Innovation Council, Hadean Ventures, Invivo Partners, Sound Bioventures, and other unspecified investors also participated in the round. The round was part of a larger USD 87 million series B funding. The company will use the funding to enhance the development of its clinical trials.
Current Investors
AdBio Partners, Invivo Partners, Center for Technological & Industrial Development
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.arthexbiotech.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.